BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?

Journal article

Open access

Peer reviewed

Kieron Dunleavy, R Eric Davis, Ola Landgren, Louis M Staudt, Wyndham H Wilson and Carl Ola Landgren

Blood, Vol.109(2), pp.843-4; discussion 844-5

2007-01-15

PMID: 17210865

Abstract

Abridged Index Medicus

url

https://doi.org/10.1182/blood-2006-07-038000View

Published (Version of record) Open

4 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.132 Lymphoma
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?
Creators: Kieron Dunleavy
R Eric Davis - Lymphoma-Myeloma
Ola Landgren
Louis M Staudt
Wyndham H Wilson - National Institutes of Health
Carl Ola Landgren - Miller School of Medicine
Publication Details: Blood, Vol.109(2), pp.843-4; discussion 844-5
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 17210865
Record Identifier: 991031713532302976